Click Here to return To Results

 

Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke Arch Neurol 61:346-350, Katzan,I.L.,et al, 2004 See this aricle in Pubmed Article Abstract Only 15% of patients arrived within the 3-hour time window fore intravenous tPA, making delay in presentation the most common reason patients were ineligible for IV thrombolysis. Neurologic criteria were the second most common group of exclusions. Overall tPA use was low, but it was used in nearly half of all patients with no documented contraindications. Intravenous tPA use in a community setting can compare favorably with the rate of use seen in academic medical settings.

Related Tags

(click to filter results - removes previous filter) cerebrovascular accident,delay in presentation cerebrovascular accident,thrombolytic agents in treatment fibrinolytic agents fibrinolytic agents,contraindications tissue plasminogen activator,intravenous

Click Here to return To Results